Abbott Laboratories
Logotype for Abbott Laboratories

Abbott Laboratories (ABT) investor relations material

Abbott Laboratories Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Abbott Laboratories
Q4 2025 earnings summary22 Jan, 2026

Executive summary

  • Achieved double-digit adjusted EPS growth in 2025, with Q4 adjusted EPS up 12% to $1.50 and full-year adjusted EPS up 10% to $5.15, despite challenges in nutrition and China.

  • Worldwide sales reached $11.5B in Q4 and $44.3B for the full year, with organic sales growth of 3.8% in Q4 and 16.7% for the year, excluding COVID-19 testing.

  • Announced acquisition of Exact Sciences to enter the cancer diagnostics market, expected to close soon, adding a high-growth vertical.

  • Innovation and disciplined execution drove performance, with multiple regulatory approvals and new product launches across segments, including FDA and CE Mark approvals for new ablation systems.

Financial highlights

  • Q4 organic sales increased 3.8% excluding COVID testing; adjusted EPS of $1.50, up 12% year-over-year; Q4 GAAP diluted EPS was $1.01.

  • Full-year 2025 sales reached $44.3B, up 5.7% reported and 5.5% organic; excluding COVID-19 testing, organic growth was 6.7%.

  • Adjusted gross margin was 57.1% of sales, up 20 basis points; adjusted operating margin rose to 25.8%, up 150 basis points.

  • Q4 operating earnings rose 17.8% to $2.251B; adjusted net earnings were $2.63B, up 11.9%.

  • Foreign exchange had a favorable 1.4% impact on Q4 sales.

Outlook and guidance

  • 2026 guidance: adjusted EPS of $5.55–$5.80 (10% growth at midpoint); organic sales growth of 6.5%–7.5%.

  • Q1 2026 adjusted EPS forecasted at $1.12–$1.18.

  • Expect margin expansion of 50–70 basis points in 2026.

  • Anticipate return to growth in nutrition in the second half of 2026 after near-term challenges.

Exact Sciences acquisition: 2026 strategic impact
Nutrition: 2026 new product volume growth
China VBP impact on Diagnostics mitigation
What gives confidence in Nutrition pricing strategy?
EP portfolio completeness vs. competition?
Non-insulin CGM reimbursement timeline?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Abbott Laboratories earnings date

Logotype for Abbott Laboratories
Q1 202615 Apr, 2026
Abbott Laboratories
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Abbott Laboratories earnings date

Logotype for Abbott Laboratories
Q1 202615 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

The Business of Life

Abbott Laboratories is an American global and multinational healthcare company headquartered in Chicago, Illinois, and listed on the NYSE. The company is focused on manufacturing various medical devices and medications. Its products include diagnostics equipment, medical devices, nutritionals, and branded generic pharmaceuticals. Some of Abotts more well-known products include Pedialyte and FreeStyle, the latter being a monitoring system for people living with diabetes.

Sprung from a small Pharmacy

The inception of Abbott Laboratories can be traced back to 1888 when Dr. Wallace C. Abbott founded it in Chicago. Initially operating as a small pharmacy, Dr. Abbott's business focused on creating standardized drug dosages, known as "dosimetric granules", of commonly used medications. Over the decades, the company underwent significant expansion in terms of its product range and geographical outreach, transforming from its humble beginnings into a notable player in the global pharmaceutical industry.

What They Do

Abbott Laboratories offers a wide array of products and services within healthcare and nutrition. In diagnostics, it supplies tools and tests to medical facilities used in the identification of different illnesses. The company's medical devices segment manufactures equipment used in areas like cardiology, diabetes care, and neuromodulation. Additionally, they also manufacture and sell branded generic pharmaceuticals that can be purchased over the counter at pharmacies like CVS. Their portfolio of nutritional products includes products aimed both at infants and small kids, as well as adults.

Abbott Laboratories and AbbVie

In 2013, Abbott Laboratories underwent a significant transformation by spinning off its research-based pharmaceuticals division into a separate company: AbbVie. This strategic decision was aimed at allowing both companies to focus more distinctly on their respective sectors. While Abbott Laboratories retained its portfolio including medical devices, diagnostics, and nutrition, AbbVie took over the responsibility for the research-driven pharmaceutical business. This split allowed Abbott to concentrate on its extensive range of products and services, whereas AbbVie could focus on the development and commercialization of advanced therapies.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage